Ashley FL, Thompson DP, Henderson T (1973) Augmentation of surface contours by subcutaneous injections of silicon fluid. Plast Reconstr Surg 51(1):8-13

 

Balazs EA (1979) Ultrapure hyaluronic acid and its use, US patent 4141973

 

Balazs EA, Leshchiner A (1986) Water-insoluble hyaluronic acid preparation, German patent 3434082

 

Bartlett SP, Grossman R, Whitaker LA (1992) Age-related changes of the craniofacial skeleton: an anthromorphic and histologic analysis. Plast Reconstr Surg 90:592-600

 

Barton JL, Cunliff WJ (1986) Oil granuloma. In: Rook A, Wilkinson DB, Ebling FJG (eds) Textbook of dermatology, Blackwell, Oxford, pp 1870-1871

 

Baumann LS, Shamban AT, Lupo MP (2007) Comparison of smooth gel hyaluronic acid dermal fillers with crosslinked bovine collagen: A multicenter, double-masked, randomized, within-subject study.

 

Dermatol Surg 33 (Suppl. 2):128−135

 

Beer K (2007) A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne orvaricella. Dermatol Surg 33 (Suppl. 2):159-167

 

Biesman B (2004) Soft tissue augmentation using Restylane. Facial Plast Surg 20:171-177

 

Broder KW, Cohen SR (2006) An Overview of permanent and semipermanent filler. Plast Reconstr Surg 118 (Suppl.):7-15

 

Buelow S von, Heimburg D von, Pallua N (2005) Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation. Plast Reconstr Surg 116:1137-1146

 

Butterwick KJ, Nootheti PK, Hsu JW, Goldman MP (2007) Autologous fat transfer: an in-depth look at varying concepts and techniques. Facial Plast Surg Clin North Am 15:99-111

 

Carruthers A, Carey W, De Lorenzi C et al (2005) A randomized, double-blind comparison of the efficacy of two hyaluronic acid derivates, Restylane Perlane and Hylaform, in the treatment of nasolabial folds.

 

Dermatol Surg 31:1591-1598

 

Carruthers A, Carruthers J (2007) Non-animal-based hyaluronic acid fillers: scientific and technical considerations. Plast Reconstr Surg 120 (Suppl.):33-40

 

Carruthers JD, Glogau RG, Blitzer A; Facial Aesthetic Consensus Group Faculty (2008) Advances in facial rejuvenation: botulinum toxin type a hyaluronic acid dermal fillers, and combination therapies - consensus recommendations. Plast Reconstr Surg 121 (5 suppl):5S-30S; quiz 31S-36S

 

Christensen L, Breiting V, Janssen M (2005) Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 29:34-48

 

Cohen SR, Holmes RE (2004) Artecoll: A long-lasting injectable wrinkle filler material. Report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 114:964-976

 

Coleman K, Carruthers J (2006) Combination therapy with BOTOX® and fillers: the new rejuvenation paradigm. Dermatol Ther 19:177-188

 

Coleman SR (1997) Facial recontouring with lipostructure. Clin Plast Surg 24:347-367

 

Coleman SR (2004) Structural Fat Grafting. Quality Medical Publishing, St. Louis

 

Coleman SR (2006) Facial augmentation with structural fat grafting. Clin Plast Surg 33:567-577

 

De Maio M (2003) Botulinum toxin in association with other rejuvenation methods. J Cosmet Laser Ther 5:210-212

 

De Maio M (2004) The minimal approach: an innovation in facial cosmetic procedures. Aesth Plast Surg 28:295-300

 

DeLustro F, Smith TS, Sundsmo J et al (1987) Reaction to injectable collagen: results in animal model and clinical use. Plast Reconstr Surg 79(4):581-592

 

Di Pietro A, di Sante G (2001) Recovery of skin elasticity and turgor by intradermal injection of hyaluronic acid (Ial-SystemTM) by the cross linked technique. G Ital Dermato Venerol 136:187-194

 

Dijkema SJ, Lei B van der, Kibbelaar RE (2005) New-Fill injections may induce late-onset foreign body granulomatous reaction. Plast Reconstr Surg 115:76-78

 

Dirting K, Lampe H, Wolters M et al (2008) Hyaluronsäurefiller zur Korrektur der Nasolabialfalten - Ergebnisse einer klinischen Studie. JDDG 6 (Suppl. 2):S10-S14

 

Donofrio LM (2000) Fat distribution: a morphologic study of the aging face. Dermatol Surg 26:1107-1112

 

Dover JS, Carruthers A, Carruthers J, Alam M (2005) Clinical use of Restylane. Skin Ther Lett 10:5-7

 

Duranti F, Salti G, Bovani B et al (1998) Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol surg 24:1317-1325

 

Elson ML (1989) The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol 15:301-303

 

Entwistle J, Hall CL, Turley EA (1996) HA receptors: regulators of signaling to the cytoskeleton. J Subcell Biochem 61:569-577

 

Eppley BI, Dadvand B (2006) Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg 118:98-106

 

Falcone SJ, Berg RA (2008) Crosslinked hyaluronic acid dermal fillers: a comparison of rheological properties. J Biomed Mater Res 87A(1):264-271

 

Goa KL, Benfield P (1994) Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophtalmology, and its therapeutic potential in joint disease and wound healing. Drugs 47(3):536-566

 

Green MS (2007) Not all hyaluronic acid fillers are equal. Cosmetic Dermatology 20(11):724-729

 

Hamra ST (1996) The role of orbital fat preservation in facial aesthetic. Clin Plast Surg 23:17-28

 

Hardingham T (2005) Properties of hyaluronan in aqueous solution. In: Balazs EA, Hascall VC (eds)

 

Hyaluronan: structure, metabolism, biological activities, therapeutic applications, Matrix Biology Institute, pp 67-78

 

Hruby K (1961) Hyaluronsäure als Glaskörperersatz bei Netzhautablösung. Klin Monatsbl Augenheilk 138:484-496

 

Jacovella PF, Peiretti CB, Cunille DR (2006) Long lasting results with hydroxylapatite facial filler. Plast Reconstr Surg 118 (Suppl. 3):15-21

 

Jha BK, Salunke DM, Datta K (2005) Central role of hyaluronan in regulating the function of multi-ligand binding human hyaluronan binding protein 1 (HABP1). In: Balazs EA, Hascall VC (eds) Hyaluronan: structure, metabolism, biological activities, therapeutic applications, Matrix Biology Institute, pp 89-92

 

Knapp TR, Kaplan EN, Daniels JR (1977) Injectable collagen for soft tissue augmentation. Plast Reconstr Surg 60:898

 

Laurent TC, Hellsing K, Gelotte B (1964) Cross-linked gels of hyaluronic acid. Acta Chem Scand 18:274-275

 

Lemperle G, Gauthier-Hazan N, Lemperle M (1998) PMMA-microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. Aesthetic Plast Surg 22:356-365

 

Lemperle G, Gauthier-Hazan N, Wolters M (2006) Komplikationen nach Faltenunterspritzung und ihre Behandlung. Handchir Mikrochir Plast Chir 38:354-369

 

Lemperle G, Morhenn V, Charrier U (2003) Human histology and persistance of various injectable filler substances for soft tissue augmentation. Aesth Plast Surg 27:354-366

 

Lemperle G, Morhenn V, Charrier U (2003) Human histoogy and persistence of various injectable filler substances for soft tissue augnmentation. Aesthetic Plast Surg 27:354-366

 

Lenzen C (2005) Wo finden sich die Ursachen für Komplikationen nach Faltenunterspritzungen im Gesicht - beim Produkt, beim Anwender oder bei dem Patienten. Magazin für Ästhetische Chirurgie 2:23-30

 

Liesegang TJ (1990) Viscoelastic substances in ophtalmology. Surv Ophtalmol 34:268-293

 

Little JW (2000) Volumetric perceptions in midfacial aging with altered priorities for rejuvenation. Plast Reconstr Surg 105:252-266

 

Longas MO, Russel CS, He XY (1987) Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. Carbohydr Res 159:127-136

 

Lowe NJ (2003) Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol 148:379

 

Lupo MP, Smith SR, Thomas JA et al (2008) Effectiveness of Juvederm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg 121:289-297

 

Mandeville JT, Rubin PA (2004) Injectable agents for facial rejuvenation: Botulinumtoxin and dermal filling agents. Int Ophthalmol Clin 44:189-212

 

Marmur ES, Phelps R, Goldberg DJ (2004) Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther 6:223-226

 

Meyer K, Palmer J (1934) The polysaccharide of the vitreous humour. J Biol Chem 107:629-634

 

Monheit GD, Coleman KM (2006) Hyaluronic acid fillers. Dermatol Ther 19:141-150

 

Montgomery H (1987) In: Dermatopathology. Harper & Raw, New York, pp 403-415

 

Morhenn VB, Lemperle G, Gallo RL (2002) Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells. Dermatol Surg 28:484-490

 

Moyle GJ, Lysakova L, Brown S (2004) A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 5:82-87

 

Naoum C, Dasiou Plakida D (2001) Dermalfiller materials and botulinum toxin: Review. Int J Dermatol 40:609-621

 

Narins RS, Bowman PH (2005) Injectable skin fillers. Clin Plast Surg 32:151-162

 

Narins RS, Brandt F, Leyden J et al (2003) A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for correction of nasolabial folds. Dermatol Surg 29:588-595

 

Narins RS, Brandt FS, Lorenc ZP et al (2007) A randomized, multicenter study of the safety and efficacy of Dermicol-P35 and non-animal-stabilized hyaluronic acid gel for the correction of nasolabial folds.

 

Dermatol Surg 33 (Suppl. 2):213-221

 

Narins RS, Brandt FS, Lorenc ZP et al (2008) Twelve months persistency of a novel ribose-cross-linked collagen dermal filler. Dermatol Surg 34 (Suppl. 1):31-39

 

Neudecker BA, Csoka AB, Mio K (2000) Hyaluronan: the natural skin moisturizer. In: Elsner P, Maibach HI (eds) Cosmeceuticals: drugs vs. cosmetics. 1st edn. Marcel Dekker, New York, pp 319-355

 

Owsley JQ (1995) Elevation of the malar fat pad superficial to the orbicularis muscle for correction of prominent nasolabial folds. Clin Plastic Surg 22:279-293

 

Parada MB, Michalany NS, Hassun KM, Bagatin E (2005) A histologic study of adverse effects of different cosmetic skin fillers. Skinmed 4(6):345-349

 

Pearl RM, Laub DR, Kaplan EN (1978) Complications following silicone injections for the augmentation of the contours of the face. Plast Reconstr Surg 61(6):888-895

 

Quan T, He T, Kang S et al (2002) Connective tissue growth factor: expression in human skin in vivo and inhibition by ultraviolet irradiation. J Invest Dermatol 118:402-408

 

Radiesse Datasheet. Available at: www.bioformmedical.com

 

Rames RA, Aaroson IA (1991) Migration of polytef paste to the lung and brain following intravesical injection for the correction of reflux. Pediatr Surg Int 6:239-240

 

Ratner BD (1993) New ideas in biomaterials science - a path to engineered biomaterials. J Biomed Mater Res 27:837-850

 

Rees TD, Ashley FI, Delgado JP (1973) Silicone fluid injection for facial atrophy. Plast Reconstr Surg 52(2):118-127

 

Reinmüller J (1992) Die Anwendung der Hyaluronsäure als Biomaterial in der plastischen und ästhetischen Chirurgie. In: Proceedings of the 5th annual meeting of the Deutsche Gesellschaft für Ästhetische Medizin e.V., Lindau, 11-13 September 1992

 

Reinmüller J (1994) Q-plast, Studie bei Patienten mit Falten und Narben. Sponsor Q-med, Uppsala, Schweden, unveröffentlicht

 

Reinmüller J (2008) Hyaluronsäure in der ästhetischen Medizin - Historie, Entwicklung und heutige Bedeutung. JDDG 6 (Suppl. 2):4-9

 

Reinmüller J, Wolters M, Steinkraus V et al (2007) Efficacy and tolerability of the hyaluronic acid filler belotero basic after single bilateral injection for correction of the nasolabial folds. Poster no. 4321, 21st World Congress of Dermatology, Buenos Aires, Argentina, 2007

 

Reuther T, Bayrhammer J, Kerscher M (2007) Einsatz biophysikalischer Meßverfahren zur Untersuchung der hautphysiologischen Wirkung injizierbarer Hyaluronsäure. Hautarzt 48:1046-1050

 

Reuther T, Bayrhammer J, Kerscher M (2007) Einsatz biophysikalischer Messverfahren zur Untersuchung der hautphysiologischen Wirkung injizierbarer Hyaluronsäure. Hautarzt 58:1046-1050

 

Richter AW, Ryde EM, Zetterstrom EO (1988) Non-immunogenicity of a purified sodium hyaluronate preparation in man. Int Arch Allergy Appl Immunol 59:45-48

 

Sakai S, Yasuda R, Sayo T et al (2000) Hyaluranan exists in normal stratum corneum. J Invest Dermatol 114:1184-1187

 

Schwach-Abdellaoui K, Sorensen MV, Andersen KB et al (2005) Recombinant hyaluronic acid: physicochemical and thermal characterization. In: Balazs EA, Hascall VC (eds) Hyaluronan: structure, metabolism, biological activities, therapeutic applications, Matrix Biology Institute, pp 89-92

 

Selmanowitz VJ, Orentreich N (1977) Medical-grade fluid silicone: a monographic review. J Dermatol

 

Surg Oncol 3:597-611

 

Sherman RN (2006) Sculptra: the new three-dimensional filler. Clin Plast Surg 33:539-550

 

Shoshani D, Markovitz E, Cohen Y et al (2007) Skin test hypersensitivity study of a cross-linked, porcine collagen implant for aesthetic surgery. Dermatol Surg 33 (Suppl. 2):152-158

 

Tammi MI, Day AJ, Turley EA (2002) Hyaluronan and homeostasis: a balancing act. J Biol Chem 277:4581-4584

 

Tammi RH, Pasonen-Seppänen S, Kultti A et al (2005) Hyaluronan degradation in epidermis. In: Balazs EA, Hascall VC (eds) Hyaluronan: structure, metabolism, biological activities, therapeutic applications. Matrix Biology Institute, pp 241-245

 

Testimony of the FDA Commissioner, Dr. D. Kess, before the House of Representatives Human Resources Intergovernmental Relations Subcommittee, June 11, 1991, regarding "Promoting Drugs for Unproved Uses"

 

Tzikas Tl (2006) Autologous fat grafting for midface rejuvenation. Facial Plast Surg Clin North Am 118 (Suppl. 1):108-120

 

Valantin MA, Aubron-Olivier C, Ghosn J (2003) Polylactic acid implants (New Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 17:2471-2477

 

Varani J, Schuger L, Dame MK et al (2004) Reduced fibroblast interaction with intact collagen as a mechanism of depressed collagen synthesis in photodamaged skin. J Invest Dermatol 122:1471-1479

 

Vedamurthy M (2008) Standard guidelines for the use of dermal fillers. Indian J Dermatol Venereol Leprol (Suppl.):23-27

 

Wang F, Garza LA, Kang S et al (2007) In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol 143:155-163

 

Weindl G, Schaller M, Schafer-Korting M, Korting HC (2004) Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol 17:207-213

 

Wise JB, Greco T (2006) Injectable treatment for the aging face. Facial Plast Sur 22:140-146

 

Wolters M, Lampe H (2003) Nicht-operative Faltenbehandlung im Gesicht. Plastische Chirurgie 2:69-82

 

Zaoh XB, Fraser JE, Alexander C et al (2002) Synthesis and characterization of a novel double crosslinked hyaluronan hydrogel. J Mater Sci Mater Med 13:11-16

 

Zielke H, Wölber L, Wiest L, Rzany B (2007) Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg 34:1-10

 

Zimmermann US, Clerici TJ (2004) The histological aspects of fillers complications. Semin Cutan Med Surg 23:241-250